164 related articles for article (PubMed ID: 31925797)
1. Serological screening of West Nile virus among blood donors in northern Cyprus.
Balaman N; Gazi U; Imir T; Sanlidag T; Ruh E; Tosun O; Ozkul A; Taylan-Ozkan A
J Med Virol; 2020 Aug; 92(8):1035-1039. PubMed ID: 31925797
[TBL] [Abstract][Full Text] [Related]
2. [Investigation of West Nile virus seroprevalence in Hacettepe University Hospital blood donors and confirmation of the positive results by plaque reduction neutralization test].
Ayturan S; Aydoğan S; Ergünay K; Ozcebe OI; Us D
Mikrobiyol Bul; 2011 Jan; 45(1):113-24. PubMed ID: 21341166
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic significance of immunoglobulin G avidity in symptomatic and asymptomatic West Nile virus infection.
Vilibic-Cavlek T; Kristofic B; Savic V; Kolaric B; Barbic L; Tabain I; Peric L; Sabadi D; Miklausic B; Potocnik-Hunjadi T; Zember S; Stevanovic V; Listes E; Savini G
Rev Soc Bras Med Trop; 2018; 51(5):591-595. PubMed ID: 30304263
[TBL] [Abstract][Full Text] [Related]
4. Use of immunoglobulin G avidity assays for differentiation of primary from previous infections with West Nile virus.
Levett PN; Sonnenberg K; Sidaway F; Shead S; Niedrig M; Steinhagen K; Horsman GB; Drebot MA
J Clin Microbiol; 2005 Dec; 43(12):5873-5. PubMed ID: 16333069
[TBL] [Abstract][Full Text] [Related]
5. [Flavivirus seroepidemiology in blood donors in Mersin province, Turkey].
Tezcan S; Kızıldamar S; Ulger M; Aslan G; Tiftik N; Ozkul A; Emekdaş G; Niedrig M; Ergünay K
Mikrobiyol Bul; 2014 Oct; 48(4):606-17. PubMed ID: 25492656
[TBL] [Abstract][Full Text] [Related]
6. Immunoglobulin G avidity in differentiation between early and late antibody responses to West Nile virus.
Fox JL; Hazell SL; Tobler LH; Busch MP
Clin Vaccine Immunol; 2006 Jan; 13(1):33-6. PubMed ID: 16425997
[TBL] [Abstract][Full Text] [Related]
7. [Investigation of West Nile virus in central nervous system infections of unknown etiology in Ankara, Turkey].
Ergünay K; Aydoğan S; Menemenlioğlu D; Sener B; Lederer S; Steinhagen K; Hasçelik G; Pinar A; Ozkul A; Us D
Mikrobiyol Bul; 2010 Apr; 44(2):255-62. PubMed ID: 20549960
[TBL] [Abstract][Full Text] [Related]
8. A study of West Nile virus infection in Iranian blood donors.
Sharifi Z; Mahmoodian Shooshtari M; Talebian A
Arch Iran Med; 2010 Jan; 13(1):1-4. PubMed ID: 20039761
[TBL] [Abstract][Full Text] [Related]
9. Performance of immunoglobulin G (IgG) and IgM enzyme-linked immunosorbent assays using a West Nile virus recombinant antigen (preM/E) for detection of West Nile virus- and other flavivirus-specific antibodies.
Hogrefe WR; Moore R; Lape-Nixon M; Wagner M; Prince HE
J Clin Microbiol; 2004 Oct; 42(10):4641-8. PubMed ID: 15472323
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of IgM and IgG antibodies to West Nile virus among blood donors in an affected area of north-eastern Italy, summer 2009.
Pezzotti P; Piovesan C; Barzon L; Cusinato R; Cattai M; Pacenti M; Piazza A; Franchin E; Pagni S; Bressan S; Martello T; Potenza R; Scipioni C; Ammendola R; Breda A; Palu G; Russo F; Rezza G
Euro Surveill; 2011 Mar; 16(10):. PubMed ID: 21435323
[TBL] [Abstract][Full Text] [Related]
11. West Nile virus in Canadian blood donors.
Cameron C; Reeves J; Antonishyn N; Tilley P; Alport T; Eurich B; Towns D; Lane D; Saldanha J
Transfusion; 2005 Apr; 45(4):487-91. PubMed ID: 15819667
[TBL] [Abstract][Full Text] [Related]
12. West Nile Virus Seroprevalence Among Blood Donors in Hungary.
Nagy A; Szöllősi T; Takács M; Magyar N; Barabás É
Vector Borne Zoonotic Dis; 2019 Nov; 19(11):844-850. PubMed ID: 31184991
[No Abstract] [Full Text] [Related]
13. Development and persistence of West Nile virus-specific immunoglobulin M (IgM), IgA, and IgG in viremic blood donors.
Prince HE; Tobler LH; Lapé-Nixon M; Foster GA; Stramer SL; Busch MP
J Clin Microbiol; 2005 Sep; 43(9):4316-20. PubMed ID: 16145071
[TBL] [Abstract][Full Text] [Related]
14. Seroprevalence of West Nile Virus among Healthy Blood Donors from Different National Populations Residing in Qatar.
Dargham SR; Al-Sadeq DW; Yassine HM; Ahmed M; Kunhipurayil H; Humphrey JM; Abu-Raddad LJ; Nasrallah GK
Int J Infect Dis; 2021 Feb; 103():502-506. PubMed ID: 33248245
[TBL] [Abstract][Full Text] [Related]
15. Persistence of West Nile virus-specific antibodies in viremic blood donors.
Prince HE; Tobler LH; Yeh C; Gefter N; Custer B; Busch MP
Clin Vaccine Immunol; 2007 Sep; 14(9):1228-30. PubMed ID: 17652525
[TBL] [Abstract][Full Text] [Related]
16. Investigation of West Nile virus among healthy blood donors in the western part of Turkey.
Biçeroğlu SU; Karatayli E; Bayram A; Turhan A; Değirmenci A; Aydinok Y; Bozdayi AM; Sertöz ŞR
Turk J Med Sci; 2015; 45(1):84-8. PubMed ID: 25790534
[TBL] [Abstract][Full Text] [Related]
17. [Investigation of West Nile virus seroprevalence in healthy blood donors].
Hızel K; Yenicesu I; Erdal B; Yeşilyurt E; Fidan I; Kalkancı A; Dilsiz G
Mikrobiyol Bul; 2010 Jul; 44(3):425-30. PubMed ID: 21063992
[TBL] [Abstract][Full Text] [Related]
18. [Detection of West Nile virus RNA and specific antibodies in blood donors of Volgograd region].
Karan LS; Fedorova MV; Gridneva KA; Chaika AN; Romasova EI
Zh Mikrobiol Epidemiol Immunobiol; 2015; (2):65-9. PubMed ID: 26016347
[TBL] [Abstract][Full Text] [Related]
19. Seroprevalence of anti-WNV IgG antibodies and WNV-RNA in Egyptian blood donors.
Youssef SR; Eissa DG; Abo-Shady RA; Aly Fouad NT; Kattab DK; Fathey H; Abdullaha Elewa AA; Reda DM
J Med Virol; 2017 Aug; 89(8):1323-1329. PubMed ID: 27603170
[TBL] [Abstract][Full Text] [Related]
20. West Nile encephalitis outbreak in Kerala, India, 2011.
Anukumar B; Sapkal GN; Tandale BV; Balasubramanian R; Gangale D
J Clin Virol; 2014 Sep; 61(1):152-5. PubMed ID: 24985196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
